Podcasts about psychedelic science

In this expansive episode of Psychedelics Today, Joe Moore sits down with author and cultural theorist Daniel Pinchbeck to explore the evolving—and increasingly contested—role of psychedelics in society. From the hopeful spirit of transformation that animated earlier psychedelic movements to the sobering reality of biotech, branding, and political entanglement, Daniel offers a candid diagnosis of where we are—and where we might be headed. Reflecting on Psychedelic Science 2025, Daniel discusses the event's stark shift toward commercialization and industry influence. He contrasts this with his earlier work on Evolver, a movement that sought to integrate psychedelics with permaculture, alternative economics, and cultural awakening. Together, Joe and Daniel examine how the field's idealistic origins have been increasingly subjected to capitalist co-option. They also dive into deeper philosophical terrain—discussing monistic idealism, Rudolf Steiner, and the suppression of mystical and paranormal dimensions in the push to medicalize and sanitize psychedelics for mainstream acceptance. Daniel warns of the dangers of ignoring the shadow, including psychic fragmentation and what he calls "entity attachment" from ungrounded use. The conversation ranges from tech billionaires on ketamine to the geopolitical threat of authoritarianism, the weaponization of AI, and the quiet complicity of many in the psychedelic space who avoid political engagement. Daniel shares his current projects, including his Substack newsletter and a new seminar, Breaking the AI Barrier. This is a timely, unflinching exploration of psychedelics as both medicine and mirror—revealing the best and worst of our collective intentions. Can we reclaim the visionary potential of these tools from the grip of capital and control?

This is a special episode I recorded in collaboration with Joe Moore from Psychedelics Today at the largest conference in the field "Psychedelic Science 2025" in Denver last week. It very early in the morning, at 8am, and it was fabulous. Our guests: Daniel Goldberg Co-Founder and Partner at Palo Santo & Bridge Investments & Zac Kamenetz, Founder of Shefa: Jewish Psychedelic Support, Joe and me were talking about the interactions of psychedelic community, the new role of Venture Capital in 2025 and what psychedelic systems are built in the current climate to support individuals and the bigger picture. Check out this episode, it's fun and very insightful.Check out:https://www.shefaflow.org/https://palosanto.vc/ Hosted on Acast. See acast.com/privacy for more information.

In this wide-ranging conversation, journalist Mattha Busby joins Joe Moore to reflect on the shifting tone of the psychedelic movement in the wake of Psychedelic Science 2025. Based in Vancouver, Mattha has written for The Guardian, VICE, Esquire, TIME, and Wired, bringing a uniquely embedded yet critical lens to the space. They discuss the post-conference mood and the sense that the industry is sobering up—less hype, more introspection. Mattha reflects on the growing division between underground practitioners, activists, and biotech startups, and the importance of vision, ethics, and scrutiny in the midst of this cultural moment. Other topics include: Ketamine overuse and dependence, especially in social and parenting contexts The future of psychedelic nightlife, harm reduction, and mocktail bars Gender and sexual fluidity as uncovered through psychedelics Questions of IP, underground wisdom, and psychedelic ownership Psychedelics as tools for peacebuilding, especially in conflict zones The shadow side of spiritual experiences and how to spot bad actors The value of pleasure, intimacy, and human connection in the psychedelic journey Joe and Mattha also reflect on the resurgence of psychedelic use in Texas, the legacy of the Stark Club, and how Christian libertarianism and military trauma might influence unexpected policy changes. This conversation is bold, honest, funny, and thoughtful—exactly the kind of cultural critique the movement needs right now. Find Mattha on Instagram at @matthamundo and on LinkedIn at Mattha Busby. His new pocketbook on drug policy is available now.

In Episode 127 of the MAX Afterburner podcast, Whiz opens with a powerful celebration of progress in the healing space. He highlights Robert F. Kennedy Jr.'s recent statement to Congress, where the HHS secretary boldly called for psychedelic therapies to be made available to veterans within the next 12 months. Whiz also spotlights a landmark five-year study from The Ohio State University showing that a single heroic dose of psilocybin helped 67% of participants recover from depression—with no relapse.Whiz then offers a transparent debrief on why the No Fallen Heroes Foundation didn't attend the Psychedelic Science conference in force - 'a self licking ice cream cone & echo chamber'. He expresses concern over the commercialization of the healing movement and directly calls out several for-profit ibogaine clinics in Mexico for price gouging vulnerable veterans and families in crisis. “Healing shouldn't come with a luxury price tag,” he says.The episode takes a deeper turn as Whiz addresses recent criticism surrounding Operation Midnight Hammer and the perceived contradiction of “celebrating war” while preaching healing. He responds with clarity and conviction, saying he is against all war—calling it the ultimate failure of human consciousness. But, he argues, if war must happen, it should be so brutal and unforgiving that it deters future conflict. He also shares a powerful reflection on the archetype of “the man who wanted to be left alone,” framing it as a cautionary tale for a world that pushes healed warriors too far.Finally, Whiz reflects on the last four years of his own journey—filled with setbacks, breakthroughs, and relentless work. He declares this moment “the end of the beginning”—and affirms that the real mission, the deeper healing and transformation, begins now.

Acaba de acontecer em Denver, no Colorado, a maior conferência de ciência psicodélica do mundo, que recebeu 8 mil visitantes e contou com mais de 500 palestrantes que apresentaram as últimas novidades na pesquisa científica com psicodélicos. Neste episódio, trocamos uma ideia com a Fernanda Palhano, engenheira e neurocientista do Instituto do Cérebro da UFRN (Universidade Federal do Rio Grande do Norte), que participou do evento junto com um grupo de outros renomados cientistas que estudam a aplicação de psicodélicos para a saúde mental.A comitiva brasileira da qual Fernanda faz parte foi o destaque absoluto da Psychedelic Science 2025, apresentando achados recentes com ayahuasca, DMT e cetamina, provando mais uma vez que o Brasil está entre os três países do mundo mais avançados nessa área.Aperta o play e vem comigo conhecer os insights sobre a maior conferência psicodélica do mundo!***Encontre a Fernandano Linkedinhttps://www.linkedin.com/in/fernanda-palhano-fontes-453915207/no Instahttps://www.instagram.com/fernanda_palhano/no emailfernandapalhano@neuro.ufrn.brEncontre o Camphttps://www.camp-sci.com/pt***Fernanda indicaLivros do Marcelo LeitePsiconautasA ciência encantada de Jurema***MARCAS APOIADORAS DA 4ª TEMPORADAUnyleya: https://unyleya.edu.br/anitakreppUSA Hemp: https://www.usahempbrasil.com/Flora Urbana: https://floraurbana420.com.br/Blis: https://appblis.com.br/aLeda: https://www.instagram.com/aledaoficial/***Essas são marcas que reconhecem o valor da comunicação responsável e do jornalismo de qualidade no processo de desestigmatização da planta, promovendo informação para a normalização do que um dia foi tabu.***Para seguir por dentro dos avanços da cannabis e dos psicodélicosAssine a news: https://cannabishoje.substack.com/Siga no Insta: https://www.instagram.com/cannabishoje/Se inscreva no Youtube: https://www.youtube.com/@cannabishojeAcesse: https://cannabishoje.com.br/

Join host Gregg Masters on this special episode with Jim Tate as they dive into the upcoming MAPS Psychedelic Science 2025 conference—from June 16–20th in Denver, CO. They explore the evolving science and policy landscape around psychedelic-assisted therapies for trauma and mental health, with a special focus on veterans and first responders. Tune in to hear insights on MDMA and psilocybin trials, federal and VA implementation, peer support models, and the role of community and cultural healing. With voices from researchers, practitioners, and lived-experience advocates, this episode previews what promises to be a transformative moment in public health. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Support the show:https://www.paypal.me/Truelifepodcast?locale.x=en_USBuy Grow kit: https://modernmushroomcultivation.com/This Band willl Blow your Mind! Codex Serafini: https://codexserafini.bandcamp.com/album/the-imprecation-of-animaLeaving Psychedelic Science, thoughts, highlights & the future of Psychedelics…Sabbahttp://linkedin.com/in/sabbanazhandJackhttps://linktr.ee/JackGorsline?utm_source=linktree_profile_share<sid=7e7b5bf8-8996-4502-a1d0-57ade0c01233 Support the show:https://www.paypal.me/Truelifepodcast?locale.x=en_USCheck out our YouTube:https://youtube.com/playlist?list=PLPzfOaFtA1hF8UhnuvOQnTgKcIYPI9Ni9&si=Jgg9ATGwzhzdmjkgGrow your own:https://modernmushroomcultivation.com/This Band Will Blow Your Mind: Codex Serafinihttps://codexserafini.bandcamp.com/album/the-imprecation-of-anima

This is a special episode I recorded in collaboration with Joe Moore from Psychedelics Today at the largest conference in the field "Psychedelic Science 2025" in Denver last week. It very early in the morning, at 8am, and it was fabulous. Our guests: Tommaso Barba, Neuroscientist from Imperial College London and Dee Dee Goldpaugh, therapist, author and clinical consultant, me and Joe were talking about Sex, Intimacy and Psychedelics! Check out this episode, it's fun and very insightful.IG: @Tommaso.barba @deedeegoldpaugh @psychedelicstoday Hosted on Acast. See acast.com/privacy for more information.

Support the show:https://www.paypal.me/Truelifepodcast?locale.x=en_USBuy Grow kit: https://modernmushroomcultivation.com/This Band willl Blow your Mind! Codex Serafini: https://codexserafini.bandcamp.com/album/the-imprecation-of-animaJenny Chen RobertsonIn an empire of numbness, where sedation is sold as salvation,One woman dares to weaponize wisdom and baptize bureaucracy in the psilocybin sacrament.”Jenny is not a facilitator.She is a forger of frameworks,A cartographer of care,Turning risk-reduction into revolution.She walks the fault line between clinical ethics and ecstatic experience—MBA-trained, yes—But with soul credentials inked in sweat, in silence,In sacred listening.She's briefed lawmakers with the calm of a nun and the clarity of a sniper.She's testified with tremors in her voice and steel in her spine.Her resume reads like a paradox:Real estate magnate turned mycelial matriarch.Spreadsheet whisperer turned soul doula.Jenny co-founded the Safer Psychedelics Association of New EnglandNot to play nice with power—But to redefine it.She speaks for the trip-gone-sideways,For the mothers who don't trust “the system,”For the cops confused by consciousness,For the firemen called to burning minds.This isn't harm reduction—it's harm revolution.This isn't education—it's uncolonized knowing.She doesn't just talk set and setting—She re-sets the setting of the entire conversation.So lean in close, fam—Because when Jenny speaks,The old paradigm doesn't just shudder—It begs for a blindfold.And the future?It's already listening.SPAN: Safer Psychedelics Association of New EnglandJenny Chen Robertson Support the show:https://www.paypal.me/Truelifepodcast?locale.x=en_USCheck out our YouTube:https://youtube.com/playlist?list=PLPzfOaFtA1hF8UhnuvOQnTgKcIYPI9Ni9&si=Jgg9ATGwzhzdmjkgGrow your own:https://modernmushroomcultivation.com/This Band Will Blow Your Mind: Codex Serafinihttps://codexserafini.bandcamp.com/album/the-imprecation-of-anima

Hoje eu trago para vocês um papo emocionante com Marilene Esperança, primeira mulher negra a comandar uma associação de pacientes de cannabis no Brasil, a Abrario, que recentemente obteve na Justiça do Rio de Janeiro o direito de cultivar, manipular, transportar e distribuir maconha para fins terapêuticos aos associados. A decisão destaca que nem Anvisa e nem a União podem restringir o cultivo medicinal, uma vez que não há legislação específica que o proíba. Marilene detalha como esse processo inédito se desenrolou e como agora inspira outras associações, inclusive as mais antigas que a Abrario, a buscar o mesmo direito.Vem comigo pra entender a conquista inédita da Abrario e que a Anvisa não apita em associação de pacientes.***Encontre a Marilenehttps://www.instagram.com/marilene_esperanca/Encontre a Abrariohttps://www.instagram.com/abrariooficial/***Marilene indicaIlegal, a vida não espera (documentário no Youtube)***Cobertura do Psychedelic Science 2025 para o Poder360https://www.poder360.com.br/tag/psychedelic-science-conference/***MARCAS APOIADORAS DA 4ª TEMPORADAUnyleya: https://unyleya.edu.br/anitakreppUSA Hemp: https://www.usahempbrasil.com/Flora Urbana: https://floraurbana420.com.br/Blis: https://appblis.com.br/aLeda: https://www.instagram.com/aledaoficial/***Essas são marcas que reconhecem o valor da comunicação responsável e do jornalismo de qualidade no processo de desestigmatização da planta, promovendo informação para a normalização do que um dia foi tabu.***Para seguir por dentro dos avanços da cannabis e dos psicodélicosAssine a news: https://cannabishoje.substack.com/Siga no Insta: https://www.instagram.com/cannabishoje/Se inscreva no Youtube: https://www.youtube.com/@cannabishojeAcesse: https://cannabishoje.com.br/

Support the show:https://www.paypal.me/Truelifepodcast?locale.x=en_USBuy Grow kit: https://modernmushroomcultivation.com/This Band willl Blow your Mind! Codex Serafini: https://codexserafini.bandcamp.com/album/the-imprecation-of-animaLewis Goldberg Ladies and gentlemen, seekers of signal in the static,allow me to introduce a voice forged in the alchemical fireof policy, purpose, and paradox.Lewis Goldberg is not just a publicist.He's a linguistic locksmith,a master of messaging who doesn't just shape narratives —he whispers to the current underneath them.With the war drums of old Washington echoing in his blood,he cut his teeth in the mythos of power:Clinton's campaign trail, Torricelli's tightropes,the ever-calculating eye of a First Lady named Hillary.But then —like any good archetypal wanderer —he turned toward the plant path.Toward cannabis, toward psychedelics,toward the revolution happening beneath our feet.He didn't just pivot — he prophesied.In 2015, he helped launch KCSA's cannabis division,giving shape and story to an industryrising like smoke through the cracks of a crumbling paradigm.He co-hosts The Green Rush,a podcast that is part intelligence briefing,part esoteric transmission for the business-minded psychonaut.And while some men worship quarterly reports,Lewis builds cathedrals in the stock ticker —rooting for the underdogs,channeling the sacred absurdity of Mets games,Jets heartbreaks,and the eternal optimism of Rutgers fanswho believe — against all odds —that truth, like victory, can be summoned with enough heart.So today, as we stand on the thresholdof Psychedelic Science 2025,we welcome not just a strategist —but a conjurer of attention.A myth-maker of market forces.A Blakean bard in a tailored blazerwho reminds us that even in the most corporate corners of culture…something sacred still wants to break through.Give it up for Lewis Goldberg. Support the show:https://www.paypal.me/Truelifepodcast?locale.x=en_USCheck out our YouTube:https://youtube.com/playlist?list=PLPzfOaFtA1hF8UhnuvOQnTgKcIYPI9Ni9&si=Jgg9ATGwzhzdmjkgGrow your own:https://modernmushroomcultivation.com/This Band Will Blow Your Mind: Codex Serafinihttps://codexserafini.bandcamp.com/album/the-imprecation-of-anima

A major psychedelics conference wraps up in Denver today. Its mission is to get more people, especially policy makers, comfortable with what has been underground. We speak with the founder of MAPS, the Multidisciplinary Association of Psychedelic Science, about the science and what's left to learn as Colorado licenses psilocybin healing centers. Plus a company in clinical trials, and an awareness campaign about the potential risks. Then, nurse Tara Rynders used to hold in all the trauma of the job. But through music and movement, she's managed to change that for herself and for other practitioners. Now she has a one-woman show, "A Nurse is Calling."

n this episode of Psychedelics Today, kicking of Psychedelic Science 2025 week in Denver, we sit down with Jonathan Dicksinson, Chief Executive Officer, and Trevor Millar, Chief Operations Officer of Ambio Life Sciences – one of the world's leading ibogaine clinics – to explore the potential of ibogaine for addiction, neuroregeneration, and how ethics, honoring experience, and sustainability will be key to delivering ibogaine at scale.  Trevor shares his early work supporting marginalized populations in Vancouver's Downtown Eastside, which led to the founding of Liberty Root, one of Canada's first ibogaine clinics. Jonathan reflects on his apprenticeship in Mexican clinics, years of international advocacy with the Global Ibogaine Therapy Alliance, and drafting the first set of clinical guidelines for ibogaine detoxification. Together with paramedic and ibogaine safety protocols expert Jose Inzunza, they co-founded Ambio in Tijuana in 2021. They discuss: The unique safety standards Ambio has pioneered – including industry-wide clinical protocols and magnesium therapy to mitigate cardiac risk. Their scale: over 3,000 patients treated, with 100+ clients per month across five dedicated houses in Baja California. Ambio's groundbreaking neuroregenerative program for Parkinson's, MS, and traumatic brain injury – which has already drawn patients like Brett Favre and Clay Walker. How ibogaine appears to drive profound physiological change – including evidence of TBI reversal as shown in Stanford's 2024 study on Special Forces veterans. Why ibogaine isn't just a molecule – it opens a long-lasting “critical period” of neuroplasticity that must be supported with preparation, integration, and holistic care. The deeper story of sourcing: through his company Terragnosis, Jonathan is the only person with a legal export license for Tabernanthe iboga from Gabon, and Ambio is setting a precedent for reciprocal and ethical global supply chains. Their cautionary perspective on Texas' $50M push toward ibogaine clinical trials – and why the traditional “one drug, one indication” model misses the complexity and promise of psychedelic healing. They also make a compelling case that Ambio is already modeling what the future of psychedelic care should look like – not a single drug in a sterile clinical setting, but a comprehensive, integrated protocol combining preparation, medical oversight, and deep integration. “Start with the end in mind,” Trevor urges – Ambio isn't just part of the movement; it's the blueprint for how ibogaine could be delivered worldwide. Links: Ambio Website: https://ambio.life/ Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis (Frontiers in Immunology, Feb 2025) Magnesium–ibogaine therapy in veterans with traumatic brain injuries (Nature Medicine, Jan 2024) Ibogaine reduced severe neuropathic pain associated with a case of brachial plexus nerve root avulsion (Frontiers in Pain Research, Aug 2023) Novel treatment of opioid use disorder using ibogaine and iboga in two adults (Journal of Psychedelic Studies, Jan 2020) Clinical Guidelines for Ibogaine-Assisted Detoxification Ambio Life Sciences Launches World's First Clinical Ibogaine Program for Patients With Neurodegenerative Conditions Bios:  Jonathan Dickinson is the Chief Executive Officer and Co-Founder of Ambio Life Sciences. One of the world's leading experts on ibogaine, Jonathan brings over 15 years of experience in clinical care, traditional practice, and psychedelic research to his leadership at Ambio. A Mexico-licensed psychologist and former Executive Director of the Global Ibogaine Therapy Alliance, he authored the field's foundational safety guidelines and has published widely on ibogaine's therapeutic, cultural, and ecological significance. He holds the only active export license for Tabernanthe iboga root, led the first Nagoya-compliant export from Gabon, and was initiated into the Dissoumba/Fang tradition of Bwiti in 2014 and the Missoko tradition in 2022. He has co-authored peer-reviewed research on ibogaine's potential for trauma, TBI, pain, MS, and Parkinson's. At Ambio, he leads strategy, research, and innovation – advancing a globally scalable model of care that bridges tradition, science, and integrity. Trevor Millar is the Chief Operating Officer and Co-Founder of Ambio Life Sciences. A social entrepreneur and pioneer in ibogaine advocacy and treatment, Trevor brings over a decade of experience supporting individuals through addiction recovery, trauma healing, and post-treatment integration. His background includes co-founding the Canadian Psychedelic Association and serving as Chair of the Board for MAPS Canada. He has co-authored peer-reviewed research on ibogaine's applications for trauma, TBI, and opioid use disorder, and has been featured in award-winning documentaries including DOSED and In Waves and War. Grounded in personal experience and guided by a philosophical approach to healing, Trevor is helping shape a new model for ethical, integrative psychedelic care on a global scale. At Ambio, Trevor leads operations, strategic partnerships, and client experience – bridging clinical care with systems design, education, and public advocacy.

Psychedelic therapy is on the verge of reshaping mental health, trauma healing, and human consciousness. This episode reveals what's really happening behind the scenes at the FDA, inside pharmaceutical companies, and within the global movement to legalize MDMA-assisted therapy. Watch this episode on YouTube for the full video experience: https://www.youtube.com/@DaveAspreyBPR Host Dave Asprey sits down with Rick Doblin, PhD, the legendary founder of MAPS and one of the most influential figures in psychedelic science. With nearly 40 years leading clinical research on MDMA, psilocybin, and trauma healing, Rick brings unmatched insight into how these compounds are transforming functional medicine, emotional resilience, and neuroplasticity. They break down the regulatory battle over MDMA therapy, the clash between pharmaceutical profit and public benefit, and the urgent need to combine pharmacology with therapy for real results. You'll also learn how psychedelics impact neurohacking, epigenetics, and the default mode network—and why the next frontier of self-transformation may be couples therapy with MDMA. This episode offers critical knowledge for anyone serious about biohacking, trauma release, mental performance, and accessing deeper states of healing. This podcast channel dives into the intersections of psychedelics with fasting, ketosis, cold therapy, and self-quantification—and how altered states can unlock more energy, better relationships, and lasting change. You'll Learn: • Why separating therapy from psychedelics is the most dangerous path forward • How MAPS evolved into a public benefit pharma company—and what went wrong • The real story behind the FDA's rejection of MDMA therapy in 2024 • How MDMA affects neuroplasticity, mitochondria, and trauma recovery • Why group therapy and couples therapy are the future of psychedelic healing • The dangers of overusing ketamine—and how it's being exploited by profit-driven clinics • What the Psychedelic Science 2025 conference will reveal about the future of medicine, spirituality, and consciousness hacking • How psychedelics could reverse epigenetic trauma passed down through generations • The role of default mode network suppression in spiritual experiences and trauma resolution • Why the war on drugs was never about safety—and what a post-drug-war world might look like Dave Asprey is a four-time New York Times bestselling author, founder of Bulletproof Coffee, and the father of biohacking. With over 1,000 interviews and 1 million monthly listeners, The Human Upgrade is the top podcast for people who want to take control of their biology, extend their longevity, and optimize every system in the body and mind. Each episode features cutting-edge insights in health, performance, neuroscience, supplements, nutrition, neurohacking, emotional intelligence, and conscious living. Episodes are released every Tuesday and Thursday, where Dave asks the questions no one else dares, and brings you real tools to become more resilient, aware, and high performing. SPONSORS: - Leela Quantum Tech | Head to https://leelaq.com/DAVE for 10% off- ARMRA | Go to https://tryarmra.com/ and use the code DAVE to get 15% off your first order Resources: • Dave Asprey's New Book - Heavily Meditated: https://daveasprey.com/heavily-meditated/ • Psychedelic Science Conference 2025 Website – https://www.psychedelicscience.org/ • Rick's Website: https://maps.org/ • Danger Coffee: https://dangercoffee.com • Dave Asprey's Website: https://daveasprey.com • Dave Asprey's Linktree: https://linktr.ee/daveasprey • Upgrade Collective – Join The Human Upgrade Podcast Live: https://www.ourupgradecollective.com • Own an Upgrade Labs: https://ownanupgradelabs.com • Upgrade Labs: https://upgradelabs.com • 40 Years of Zen – Neurofeedback Training for Advanced Cognitive Enhancement: https://40yearsofzen.com Timestamps: • 00:00 Trailer • 02:00 Intro • 03:43 Rise of Psychedelic Pharma • 05:00 Therapy vs. Profit • 06:44 Neurofeedback + Psychedelics • 08:28 Origins of Drug Laws • 14:06 MDMA Safety + Usage • 16:32 Psychedelics in Therapy + Meditation • 25:18 Psychedelic Hierarchy for New Users • 26:51 Psychedelic Churches + Culture • 28:58 Ayahuasca: Spiritual Insights • 30:24 MDMA and Federal Policy • 31:09 Inside the FDA Decision • 32:52 Therapeutic Promise of Psychedelics • 34:43 Psychedelics + Spirituality • 37:37 Neuroscience of Psychedelics • 40:12 Epigenetics + Generational Trauma • 43:50 War on Drugs Revisited • 46:37 Future of Legalization • 49:55 MDMA for Couples • 51:29 Group Therapy with Psychedelics • 52:26 Psychedelic Science 2025 Preview See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Matt Xavier is a full-time psychedelic guide, DJ, and mental health counselor whose remarkable career has spanned more than three decades at the intersection of music, healing, and expanded states of consciousness. In the early 1990s, Matt gained prominence as “Matthew Magic,” a pioneering force in New York City's underground electronic music scene. As cofounder of Tsunami Productions, he introduced Psychedelic Trance to the North American East Coast and later founded the influential techno label Railyard Recordings. Throughout his tenure, he held DJ residencies in both New York and Los Angeles, performing at renowned festivals and clubs around the world. Educated at Loyola Marymount University and credentialed in California, Matt has worked as a certified Gestalt therapist and co-occurring addiction counselor, providing evidence-based care at leading treatment centers across Los Angeles. In 2019, he received formal training in psychedelic-assisted therapy and launched Integrated Psychedelics—a private practice offering harm-reduction therapy, integration counseling, and immersive, music-enhanced psychedelic journeys. Through his work with Therapeutic DJing, Matt teaches others how to harness the powerful synergy between music and psilocybin-assisted therapy to support emotional release, healing, and deep personal transformation. Career News: Book release Early June 2025:  The Psychedelic DJ - A Practical Guide to Therapeutic Music Curation and Psilocybin-Assisted Therapy DJ Sets @ Psychedelic Science Conference June 2025: Shulgin 100 Year Birthday Celebration @ Psychedelic Science 2025 - Denver, feat. Oona Dahl & Matt Xavier AFTERGLOW: unofficial ambient-techno afterhours for Psychedelic Science 2025 - Denver, feat. Oona Dahl & Matt Xavier Matt's Links Mr. Bill's Links

GUEST:   https://www.wildwisebotanicals.com/   https://www.instagram.com/wildwisebotanicals/   MENTIONS:   https://momyco.org/   https://www.amazon.com/Missouris-Wild-Mushrooms-Maxine-Stone/dp/1887247742   https://namyco.org/  https://mycota.com/   https://www.fs.usda.gov/r09/marktwain   MUSHROOM HOUR:   https://welcometomushroomhour.com    https://instagram.com/welcome_to_mushroom_hour   https://tiktok.com/@welcome_to_mushroom_hour   Show Music courtesy of the one and only Chris Peck: https://peckthetowncrier.bandcamp.com/   TOPICS COVERED:   Growing up in Rural Ozarks   Crohns Disease   Wild Medicine    Homesteading and Homeschooling   The Ozarks as an Understudied Bioregion   Missouri Mycological Society   Maxine Stone   Certified Mushroom Identifiers   Developing Mushroom Certification Courses   Genetic Sequencing     Wildwise Botanicals  “Foraging Mushrooms of the Ozarks”    

From psychedelic breakthroughs to breaking the boundaries of compassion, Duncan Trussell and Raghu Markus offer unfiltered wisdom on the messy magic of waking up.Take the opportunity to support Ram Dass' Love Serve Remember Foundation and step into another dimension with a one-of-a-kind pair of custom Midnight Gospel sneakers. Hand-crafted by The Shoe Surgeon to replicate the iconic shoes worn by Clancy himself in the groundbreaking animated series by Duncan Trussell and Pendleton Ward. All proceeds benefit the Love Serve Remember Foundation and their work to preserve and continue the teachings of Neem Karoli Baba and Ram Dass. CLICK HERE to bid on the shoes and find more exciting one-of-a-kind collector's items at the LSRF Auction HERE.This time on Mindrolling, Duncan and Raghu connect over: The Good Friday psychedelic experiment New MDMA research with octopuses and insights into social neuroscienceBrain scans of Tibetan monks practicing loving-kindness (Metta) meditation‘Making the most' of the neuroplasticity that can occur during a psychedelic experience The most powerful issue we have to deal with: identity Transactional compassion versus offering genuine love and care to all Reversing our own neurosis and breaking through the self-created boundaries of compassionEmbracing spiritual discipline through the daily grind of practiceMoving through what the Buddhists call ‘the original heart of sadness' Maladaptive behaviors that we develop to mask the pain of humanity Alcohol as the west's faulty ‘ayahuasca' and initiation practice Self-compassion and allowing ourselves to be humanToday's episode is sponsored by Psychedelic Science 2025 & Reunion:Join the most important psychedelic gathering of the year......bridging science, spirit & society at Psychedelic Science 2025: THE INTEGRATION, hosted by the Multidisciplinary Association for Psychedelic Studies. Be part of the movement that will shape the next era of mental health, medicine, and consciousness.Featuring speakers like Paul Stamets, United States Representative Tim Ryan, Rick Doblin, founder of Internal Family Systems (IFS) Richard Schwartz, Pilar Guzman, CEO/Medical Director of the APA Marketa M. Wills, Raghu Markus, comedian Reggie Watts, musicians TYCHO & Jim James, and many more!Listeners get 15% off tickets to the 5-day event with our promo code LSRF15 at PsychedelicScience.orgMindrolling is brought to you by Reunion. Reunion is offering $250 off any stay to the Love, Serve, Remember community. Simply use the code “BeHere250” when booking. Disconnect from the world so you can reconnect with yourself at Reunion. Hotel | www.reunionhotelandwellness.com Retreats | www.reunionexperience.orgAbout Duncan Trussell:Duncan Trussell is a stand-up comedian, podcaster, and actor. His popular podcast, The Duncan Trussell Family Hour, has been downloaded over 25 million times and is known for its blend of humor, fringe ideas, eclectic guests, and great interviews. The DTFH is the foundation for Duncan's Netflix animated series, The Midnight Gospel, which he co-created with Pendleton Ward in 2020. To learn more about Duncan's work, visit his website at duncantrussell.com.“What do you do when you're passing strangers in the street and you love them completely? It's not bullshit. You feel about them the way you feel about someone you love, like your mother. What happens when the boundary of compassion breaks through and there is no longer this person deserves compassion, this person doesn't. It's like a dam broke." – Duncan TrussellSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this interview from 1977, Ram Dass shares his views on psychedelics and how they can provide a free slate to experience the innocence of consciousness once again. Join the most important psychedelic gathering of the year......bridging science, spirit & society at Psychedelic Science 2025: THE INTEGRATION, hosted by the Multidisciplinary Association for Psychedelic Studies. Be part of the movement that will shape the next era of mental health, medicine, and consciousness.Featuring speakers like Paul Stamets, United States Representative Tim Ryan, UCSF Neuroscience & Psychopharmacology Researcher Robin Carhartt-Harris, Rick Doblin, founder of Internal Family Systems (IFS) Richard Schwartz, Pilar Guzman, CEO/Medical Director of the American Psychiatric Association Marketa M. Wills - M.D., M.B.A., FAPA, Raghu Markus, comedian Reggie Watts, musicians TYCHO & Jim James, and many more!Listeners get 15% off tickets to the 5-day event with our promo code LSRF15 at PsychedelicScience.orgThis episode of Here and Now is from an interview with Ram Dass conducted by New Dimensions Radio in 1977, shortly after Ram Dass participated in a conference called “LSD – A Generation Later.” The interview begins with Ram Dass discussing the happenings at the conference and his interactions with other psychedelic luminaries, including Timothy Leary, Ralph Metzner, and Albert Hofmann. Ram Dass explores the culture surrounding LSD in 1977, and how he has no desire to legislate how other people live their lives. He shares his guru's instructions for using the “yogi medicine” and talks about whether or not it's important to have a guide for psychedelic experiences.Finally, Ram Dass cautions that “getting high and seeing” is only one part of the process of change, and there are inner processes necessary to bring about change in life. He discusses the cultural evolution brought about by psychedelics and the shifts in consciousness he sees taking place. The Ram Dass community gathers regularly to engage in meaningful discussions about the podcast. We invite you to join us and share your curiosities, insights, and wisdom. Sign up for the General Fellowship to receive event invitations directly in your inbox.Sponsors of this Episode:This show is sponsored by Magic Mind, a matcha-based energy shot infused with nootropics and adaptogens designed to crush procrastination, brain fog, & fatigue. Check out their new Maxx & Free energy shots and get 60% off your subscription with our code RAMDASS60 at magicmind.com/ramdassmfRam Dass Here & Now is also brought to you by BetterHelp. Give online therapy a try at betterhelp.com/ramdass and get on your way to being your best self.Reunion is offering $250 off any stay to the Love, Serve, Remember community. Simply use the code BeHere250 when booking. Disconnect from the world so you can reconnect with yourself at Reunion. Hotel | www.reunionhotelandwellness.com Retreats | www.reunionexperience.org“If you have a guide, you're calm, and you really want to explore your inner being, I still see LSD as an incredible vehicle for overriding your habitual response patterns, your habits of thought, and giving you a free slate to experience your innocence of consciousness once again.” – Ram DassSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode of The Psychedelic Podcast, Paul F. Austin welcomes back Rick Doblin, Ph.D., Founder and President of MAPS (Multidisciplinary Association for Psychedelic Studies), for a deeply personal and visionary conversation on the recent FDA rejection of MDMA-assisted therapy. Find full show notes and links here: https://thethirdwave.co/podcast/episode-306/?ref=278 Rick opens up about the painful setbacks, internal missteps, and his own process of recovery and renewed hope. He explains why this isn't the end—but a critical turning point for psychedelic medicine. Rick and Paul unpack the nuances of drug plus therapy, exploring why context, integration, and culture matter as much as pharmacology. They reflect on the future of MAPS, the psychedelic renaissance beyond FDA approval, and how business, politics, and spirituality intersect with healing. The episode also explores Rick's enduring belief in public benefit models, global collaboration, and the potential of a spiritualized humanity. Rick Doblin, Ph.D., is the Founder and President of MAPS. He received his doctorate in Public Policy from Harvard's Kennedy School of Government, and has spent nearly four decades advancing the safe and legal use of psychedelics and marijuana through science, education, and advocacy. Highlights: The cost of MAPS' quiet period Why MDMA therapy was rejected by FDA Pharma vs. therapy: What's best for patients? Drug-only treatments vs. integrated therapy Ibogaine's role in brain healing and PTSD MAPS' path forward: Phase 4 vs. Phase 3 What the Dutch got right about MDMA Spiritualized humanity and self-transcendence The global impact of MAPS' work Business, love, and psychedelic ethics Want to attend this year's Psychedelic Science 2025 Conference? For our community: Use code THIRDWAVE15 for 15% off registration. Learn more and register at psychedelicscience.org — See you there! Episode Links Psychedelic Science 2025 Conference MAPS Website Psychedelic Science on Instagram MAPS on Instagram Psychedelic Science on LinkedIn MAPS on LinkedIn Psychedelic Science on X Episode Sponsors: Golden Rule Mushrooms - Get a lifetime discount of 10% with code THIRDWAVE at checkout Psychedelic Coacing Isntitute's Intensive for Psychedelic Professionals in Costa Rica - a transformative retreat for personal and professional growth.

In this episode of Perspectives, we speak with Benjamin Breen and Jonathan Moreno on the history of psychedelic drugs in America. There is a resurgence of interest in psychedelics in the medical world as possible treatments for conditions such as depression, anxiety, and PTSD. This resurgence comes after a period during which psychedelic drugs were thought to be dangerous and have no medical value. An earlier perception was more optimistic. Figures such as Margaret Meade and Timothy Leary looked to drugs like peyote and LSD to allay fears, provide insights, broaden cultural perspectives and lead to chemical enlightenment. As mainstream institutions take yet another look, join us to examine the changing legal, medical and cultural perspectives on psychedelic drugs. Benjamin Breen is Associate Professor of history at the University of California, Santa Cruz. His second book is Tripping on Utopia: Margaret Meade, the Cold War and the Troubled Birth of Psychedelic Science. In addition to his academic publications, his writing has appeared in the The Washington Post, Paris Review Daily, The Atlantic, Slate, Aeon, The Pacific Standard, The Chronicle of Higher Education, The Public Domain Review, Nautilus, and Lapham's Quarterly. Jonathan Moreno is the David and Lyn Silfen University Professor Emeritus at University of Pennsylvania, where he works on bioethics, health policy, and the history and sociology of biology and medicine. He is the author of six books and numerous academic papers, and his work as also appeared in the New York Times, Wall Street Journal, Science, Nature, Slate, Politico, The Hill and Foreign Affairs. For more information on this and other topics, please see https://www.chstm.org/video/77474 Recorded on December 10, 2024.

Rick Doblin, Ph.D., is the founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS), a nonprofit established in 1986 to advance evidence-based psychedelic therapy and end prohibition. MAPS incubated Lykos Therapeutics (formerly MAPS Public Benefit Corporation) which is leading drug development of MDMA-assisted therapy for PTSD.  Learn more about Psychedelic Science 2025, June 16–20 at the Colorado Convention Center in Denver, at www.psychedelicscience.org, and visit www.maps.org for information on MAPS Learn more about your ad choices. Visit podcastchoices.com/adchoices

On this episode of The Zach Show, Adam Butler and Zach discuss DMT, the psychedelic molecule that Adam claims saved his life. From suicidal despair in the desert to conversations with God, demons, and dimensional beings, Adam recounts his transformation through DMT with brutal honesty and poetic grit. We unpack the “Miracle Molecule” from every angle: the effects of endogenous DMT, why it shows up at birth and death, its role in altered states, and what happens when you smoke, drink, or breathe your way into it. Adam shares his thoughts on DMT as a tool for shadow work, transcendental sex, artistic creativity, and spiritual rebirth. We also examine the fine line between mysticism and madness, and why he believes DMT is not just a drug, but a key to consciousness itself. Whether you're a seasoned psychonaut or a curious skeptic, this conversation will challenge your assumptions about reality, identity, and the nature of the soul. Guest Bio: Adam Butler is a psychedelic philosopher and passionate DMT psychonaut focusing on mental health, neuroplasticity, self-exploration, and the extreme limits of human potential and ability. He is the author of 'Butler's DMT Field Guide: A Brief History, Step-by-Step Recipes, and Personal Experiences From a DMT Saturated Consciousness' SUPPORT THE ZACH SHOW BY SUBSCRIBING TO THE ZACH SHOW 2.0 (BONUS EPISODES & EXCLUSIVE CONTENT): https://auxoro.supercast.com/ ADAM BUTLER LINKS:DMT Field Guide (Amazon): https://bit.ly/4jUQ33uInstagram: https://www.instagram.com/booksbyadambutler/YouTube: https://www.youtube.com/@ButlersDMTFieldGuide THE ZACH SHOW LINKS: Instagram: https://www.instagram.com/auxoroYouTube: https://bit.ly/3CLjEqFNewsletter: https://therealzachwrites.substack.com/TikTok: https://www.tiktok.com/@auxoropod To support the show, please leave a review on Spotify and Apple Podcasts. This nudges the algorithm to show The Zach Show to more new listeners and is the best way to help the show grow. Thank you for your support:  Review us on Apple Podcasts: https://bit.ly/458nbhaReview us on Spotify: https://bit.ly/43ZLrAt 

Zach Leary returns to Mindrolling to discuss his upcoming book on navigating the psychedelic boom of the 21st century. Preorder your copy of Zach's book, Your Extraordinary Mind: Psychedelics in the 21st Century and How to Use Them, HERE.Mindrolling is brought to you by Reunion. Reunion is offering $250 off any stay to the Love, Serve, Remember community. Simply use the code “BeHere250” when booking. Disconnect from the world so you can reconnect with yourself at Reunion. Hotel | www.reunionhotelandwellness.com Retreats | www.reunionexperience.orgThis week on Mindrolling, Raghu and Zach chat about:What propelled Zach to write his new book The explosion of psychedelic use in the 21st century Zach's personal history as the son of Timothy Leary and a close friend of Ram DassLaura Huxley's book on her father Aldous Huxley, This Timeless MomentThe film, Dying to Know, about Tim Leary and Ram DassThe origin story of LSD in the book Tripped by Norman OhlerMAPS work in redefining the modern age of psychedelics Pros and Cons of the medical movement in psychedelic research The benefits of practice coincided with psychedelics for inner expansionThe necessity of integration after a psychedelic experience Psychedelic research into neuroplasticity and transforming trauma Check out this MAPS page, where you can see a video of Ram Dass and Laura Huxley reading This Timeless Moment togetherAbout Zach Leary: Zach is a speaker, writer, Dharmic realizer, and psychedelic advocate. He is also a journey facilitator at Evolution Retreats and Heroic Path to Light. Zach hosts the MAPS (Multidisciplinary Association for Psychedelic Studies) Podcast where he explores an incredible treasure trove of audio archives sourced from the amazing talks, presentations, and panels that have taken place at past Psychedelic Science conferences and other unique events.Keep up with Zach on Instagram “I see far more success in the psychedelic sphere with people that have something to augment the experience with. If you go back to your desk on a Monday morning and are just unaware of these transformations and not making any effort to tap in, it will fade. I think it's an essential ingredient that you need to make it successful.” – Zach LearySee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

The breakthroughs we're seeing in psychedelic medicine today started with non-profit organizations taking risks that others wouldn't.Three organizations leading the charge are Multidisciplinary Association for Psychedelic Studies (MAPS), OPEN Foundation and Champalimaud Foundation.Psychedelic research faces unique hurdles, such as Schedule I drug classification, complex regulatory requirements, and historical stigma. Traditional funding sources (pharma, government and academia) often avoid these high-risk, long-term investments, which is where non-profits can make big strides. They tend to be mission-driven, patient-focused, and have a long-term commitment to research.Check out my latest Nina's Note to learn how these organizations push psychedelic research forward and act as bridge-builders between science and public understanding.

Dr. Julia Ann Koretski, a psychiatrist and Digital Editor of the Journal of Clinical Psychopharmacology (JCP), leads a conversation about the guest editorial “Ethics in Psychedelic Science: Promises and Responsibilities” with its author, Dominic Sisti, PhD, a medical ethicist from the Perelman School of Medicine at the University of Pennsylvania, and a JCP podcast panel of Editor-in-Chief Dr. Anthony Rothschild and Associate Editor Dr. Richard Balon. Dr. Sisti provides an overview of recent regulatory actions in this area and summarizes the history of “utopian hype” in the field. The editorial and the podcast discussion detail what elements are required to build a solid ethics infrastructure for psychedelics research and clinical delivery that is free of hype and bias. Sisti advises moving ahead with caution, while noting that “the range of potentially treatable conditions is wide—including PTSD, major depression, anxiety disorder, obsessive compulsive disorder, anorexia nervosa, and substance use disorders.” The guest editorial is published in the January-February 2025 issue of JCP.

Dr. Julia Ann Koretski, a psychiatrist and Digital Editor of the Journal of Clinical Psychopharmacology (JCP), leads a conversation about the guest editorial “Ethics in Psychedelic Science: Promises and Responsibilities” with its author, Dominic Sisti, PhD, a medical ethicist from the Perelman School of Medicine at the University of Pennsylvania, and a JCP podcast panel of Editor-in-Chief Dr. Anthony Rothschild and Associate Editor Dr. Richard Balon. Dr. Sisti provides an overview of recent regulatory actions in this area and summarizes the history of “utopian hype” in the field. The editorial and the podcast discussion detail what elements are required to build a solid ethics infrastructure for psychedelics research and clinical delivery that is free of hype and bias. Sisti advises moving ahead with caution, while noting that “the range of potentially treatable conditions is wide—including PTSD, major depression, anxiety disorder, obsessive compulsive disorder, anorexia nervosa, and substance use disorders.” The guest editorial is published in the January-February 2025 issue of JCP.

Welcome back to The Trip Report Podcast, a production of Beckley Waves.Today, I am speaking with Hailey Gilmore, the former Medical Science Liason at MAPS PBC, Lykos Therapeutics, and founder of Luminous Research ConsultingHailey joined MAPS in 2020, where she spearheaded their investigator-initiated trials (IIT) program, overseeing how MDMA-assisted therapy could address diverse clinical indications. Her role involved navigating complex regulatory landscapes, establishing protocols, and engaging with researchers worldwide.Today, as the founder of Luminous Research she leverages her expertise to guide organizations in bringing psychedelics and other innovative therapies to market.Hailey is a public health scientist with a master's degree in epidemiology and biostatistics from UC Berkeley. She has spent over 15 years in clinical trial management, initially in the HIV prevention field, where she contributed to groundbreaking studies such as the efficacy of pre-exposure prophylaxis (PrEP) in preventing HIV transmission.This conversation is a masterclass in understanding psychedelic therapy development's nuanced challenges and opportunities.Here's what we cover:* The Landscape of Psychedelic Therapy: Hailey breaks down the logistical hurdles of bringing MDMA-assisted therapy to market, from FDA approvals to state-by-state legislative processes and the complex interplay of insurance, healthcare institutions, and drug rescheduling.* Insights from HIV Research: Drawing parallels with PrEP's rollout, Hailey provides a framework for how psychedelics might navigate similar adoption barriers, including clinician training, insurance buy-in, and the balancing act between small, agile clinics and large academic centers.* The Role of Smaller Clinics vs. Academic Institutions: She reflects on how smaller clinics might be better positioned to implement MDMA-assisted therapy quickly, given their flexibility, while larger institutions struggle to turn their metaphorical cruise ships.* Systemic Challenges in the Psychedelic Field: From the intricacies of DEA licensing to the limitations of current research funding, Hailey outlines the systemic barriers that continue to slow progress in this field.* Optimism Amid Complexity: Despite the delays in MDMA-assisted therapy's approval, Hailey believes that public-private partnerships and innovative trial designs could unlock new opportunities for psychedelic research and implementation.Finally, we explore the potential impact of Robert F. Kennedy Jr.'s potential appointment as Secretary of Health and Human Services in the Trump administration. Could this mark a turning point for federal policy on psychedelics? Hailey weighs the possibilities and shares her vision for how public health could guide this evolving conversation.And now, I bring you my conversation with Hailey Gilmore.Listen to the episode on Substack, Spotify, Google or Apple.Credits:* Hosted by Zach Haigney* Produced by Zach Haigney, Erin Greenhouse, and Katelin Jabbari* Find us at thetripreport.com* Follow us on Instagram, Twitter, LinkedIn and YouTubeTheme music by MANCHO Sounds, Mixed and Mastered by Rollin Weary This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.thetripreport.com

In this episode, Joe interviews Rick Doblin, Ph.D.: founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS), and former board member at Lykos Therapeutics, MAPS' public benefit subsidiary. Doblin tells his side of the story: that the FDA's concerns with double blinding not working had been fully addressed ahead of time, that they had negotiated agreements that were no longer agreed to when new FDA employees came on board, that there was a lot of confusion from going back and forth with the FDA on how Phase 3 studies should be designed, and more. He believes that Lykos made a massive mistake in assuming that provable science was more important than public opinion, and that ignoring critics who were saying whatever they wanted caused them to lose control of the narrative – which clearly influenced the advisory committee. While Lykos figures out their next steps with the FDA, MAPS is focusing their attention on what they feel is most important in light of this ruling: better public education and drug policy. He talks about: How there's a bias at the FDA to be harsh: Does automatically saying no just make it look like you're being rigorous? The work of the Dutch government in researching MDMA, and Lykos' odd decision to not highlight any of it Massachusetts' Legalization and Regulation of Psychedelic Substances initiative, and the huge opportunity for progress at the local level Why federal agents at Burning Man work so hard to give tickets to attendees for smoking cannabis Why sharing stories of your positive experiences with psychedelics is so important and more!  MAPS has announced that 2025's Psychedelic Science conference will be in Denver, June 16-20, and will have experiential opportunities before and after.  For links, head to the show notes page. 

We speak with historian Ben Breen (UC Santa Cruz) about the writing of his recent book, Tripping on Utopia: Margaret Mead, the Cold War, and the Troubled Birth of Psychedelic Science, We discuss how to think about chapter organization; writing about individuals' lives without writing biography; discovering our main characters through the writing process; books that have served as models for writing; the wonderfulness of Terry Gross; not getting caught up in the apparatus of writing tools; and why it's most important to just get the ideas down. Don't forget to rate and review our show and follow us on all social media platforms here: https://linktr.ee/writingitpodcast Contact us with questions, possible future topics/guests, or comments here: https://writingit.fireside.fm/contact

Delve into the fascinating world of psychedelics with Dr. Harriet De Wit, a renowned expert in psychiatry and behavioral neuroscience. Discover what truly happens in the brain during psychedelic experiences, from the science behind microdosing to the potential of psychedelics as treatments for mood disorders and even PTSD. Dr. De Wit provides insights into the effects of MDMA and LSD, the history of these substances, and how societal perceptions are shifting. Plus, get a sneak peek into Reese's 100th Book Club pick, "The Comfort of Crows" by Margaret Renkl, and how it beautifully intertwines memoir and nature writing. See omnystudio.com/listener for privacy information.

Mona Sobhani, Ph.D., is a cognitive neuroscientist, author, and entrepreneur. A former research scientist at the University of Southern California, she holds a doctorate in neuroscience from the University of Southern California and completed a post-doctoral fellowship at Vanderbilt University with the MacArthur Foundation Law and Neuroscience Project. She is now co-founder and Head of Research at Pala, a platform that delivers trusted wisdom in short, engaging, and relatable videos using scientifically-proven methods that accelerate personal and professional growth.Her work has been featured in the New York Times, VOX, and other media outlets. She is the author of Proof of Spiritual Phenomena: A Neuroscientist's Discovery of the Ineffable Mysteries of the Universe (forthcoming September 9, 2022, Park City Press/Inner Traditions), in which she details her transformation from a diehard scientific materialist to an open-minded spiritual seeker. In the Brave New World of Psychedelic Science newsletter, she writes about the psychedelic renaissance and consciousness.Please enjoy my conversation with Mona Sobhani.Become a supporter of this podcast: https://www.spreaker.com/podcast/next-level-soul-podcast-with-alex-ferrari--4858435/support.

Rome is a kind, caring, and authentic soul. I had the pleasure of briefly meeting her at Psychedelic Science back in June of 2023. Adrian Lozano (Episode 004 and 077) works with her and suggested we get together to do a podcast as well. I wasn't sure she would remember me, but alas, she did. I say all of that to say how grateful I am to be able to release this episode that was full of laughs, realness, and beautiful pieces of wisdom.Connect with RomeMycology Psychology Website  https://www.mycologypsychology.com/Mycology Psychology Instagram: https://www.instagram.com/mycologypsychology/If you are interested in sponsoring an episode The TripSitting Podcast, send an email to tripsittingblog@gmail.comBe sure to share with a friend and subscribe so you never miss my latest posts :) Watch on YouTubeFollow on InstagramFollow on TikTok

“I would love for the psychoanalytic world to re-embrace some of these adjunctive treatments that get to non-ordinary states of consciousness in order to enhance psychoanalytic treatment, and that includes psychedelics. The other thing I'd like to see is, I think psychoanalysts are extremely well suited to use psychedelic-assisted therapy in a non-harmful way. I really believe that without an ongoing treatment relationship that these medicines are not going to be quick fixes. There's an article in the Substack blog, Ecstatic Integration, about an Israeli man who had an MDMA treatment for chronic post-traumatic stress disorder and it's a very interesting read, and it really does speak to the crucial aspect of having an ongoing therapy relationship while we use these medicines. I want people who are in the analytic field who are trained right out of the box to provide these containers to be more involved in the psychedelic field. For the psychedelic field I think sometimes I wish they would be a little more humble, a little less zealous about the efficacy, and a little more concerned about what could happen that's harmful. I also think the psychedelic field, for some reason, has not embraced psychoanalysis as a major tool to enhance the medicine."    Episode Description: Charis begins by discussing her inspiration, attributed to Maimonides, for always seeking new understandings to enhance her care of patients. We also begin with a caution - any time we introduce a frame change in clinical work, we must carefully attend to our countertransference to determine the factors that are contributing to our actions. That said, we should be careful to not use our carefulness to rationalize inhibitions to thinking and acting creatively. Charis describes her thinking underlying her decision to introduce ketamine with a particular patient as well as the process of the ongoing psychotherapy. We discuss the practical aspects of this procedure, the risks, the changes in the patient, and the importance of an ongoing psychotherapy to serve as a productive holding and processing space for this work. She concludes with her recommendation to the analytic world to be more open to such adjunctive approaches to therapy and to the psychedelic world to be more modest in their assumptions of its healing ability.   Linked Webinar and Article:  /g/Communications/Ees4tjM0U1lEtzEkVrUmDjgBmH9Vd6wgap_-Z-7BJVXNDw?e=h8Afay&referrer=Outlook.Win32&referrerScenario=email-linkwithembed">https://ipaworld.sharepoint.com//g/Communications/Ees4tjM0U1lEtzEkVrUmDjgBmH9Vd6wgap_-Z-7BJVXNDw?e=h8Afay&referrer=Outlook.Win32&referrerScenario=email-linkwithembed   https://www.ecstaticintegration.org/p/successfully-treating-c-ptsd-with?utm…     Our Guest: Dr. Cladouhos is a child, adolescent, and adult psychiatrist and psychoanalyst practicing in Boston, Massachusetts. She is on the faculty at the Tufts University School of Medicine and in the Boston Psychoanalytic Institute's adult and child analytic training programs.  She is the course director of an experiential elective for first-year medical students at Tufts called The Healer's Art: Rekindling the Heart and Soul of Medicine and established a pilot retreat program (First Aid for Physicians) through Tufts Medical Center to address physician burnout. She is trained in EMDR and Deep Brain Reorienting, has completed the first phase of MDMA training through MAPS, and has a certificate in Ketamine Assisted Psychotherapy from the Fluence Center for Psychedelic Training in New York. She is a member of the International Society for the Treatment of Trauma and Dissociation's Special Interest Group on psychoanalytic contributions to the treatment of trauma and dissociation.     Recommended Readings:    Jeffrey Guss (2022) A Psychoanalytic Perspective on Psychedelic Experience, Psychoanalytic Dialogues, 32:5, 452-468, DOI: 10.1080/10481885.2022.2106140    Fischman, Lawrence G. Knowing and being known: Psychedelic-assisted psychotherapy and the sense of authenticity. 09/20/22. Frontiers in Psychiatry. pp.1-36    Lawrence G. Fischman (2019) Seeing without self: Discovering new meaning with psychedelic-assisted psychotherapy, Neuropsychoanalysis, 21:2, 53-78, DOI: 10.1080/15294145.2019.1689528     Dahlberg, Charles Clay. LSD Facilitation of Psychoanalytic Treatment: A Case Study in Depth    Aaron D. Cherniak, Joel Gruneau Brulin, Mario Mikulincer, Sebastian Östlind, Robin Carhart-Harris & Pehr Granqvist (2023) Psychedelic Science of Spirituality and Religion: An Attachment-Informed Agenda Proposal, The International Journal for the Psychology of Religion, 33:4, 259-276, DOI: 10.1080/10508619.2022.2148061   Orbach, S. There Is No Such Thing As A Body. John Bowlby Memorial Lecture: British Journal of Psychotherapy. 20 (1) 3-15 2003   Orbach, S. Body Part 2: Psychoanalysis' Discomfort with Touch. British Journal of Psychotherapy. 20 (1) 17-26.2003.   Essentials of informed consent:   Power Trip: Cover Story New York Magazine. Lily K Ross and David Nickels 

Today I talked to Benjamin Breen about his book Tripping on Utopia: Margaret Mead, the Cold War, and the Troubled Birth of Psychedelic Science (Grand Central, 2024). The generation that survived the second World War emerged with a profoundly ambitious sense of social experimentation. In the '40s and '50s, transformative drugs rapidly entered mainstream culture, where they were not only legal, but openly celebrated. American physician John C. Lilly infamously dosed dolphins (and himself) with LSD in a NASA-funded effort to teach dolphins to talk. A tripping Cary Grant mumbled into a Dictaphone about Hegel as astronaut John Glenn returned to Earth. At the centre of this revolution were the pioneering anthropologists - and star-crossed lovers - Margaret Mead and Gregory Bateson. Convinced the world was headed toward certain disaster, Mead and Bateson made it their life's mission to reshape humanity through a new science of consciousness expansion, but soon found themselves at odds with the government bodies who funded their work, whose intentions were less than pure. Mead and Bateson's partnership unlocks an untold chapter in the history of the twentieth century, linking drug researchers with CIA agents, outsider sexologists and the founders of the Information Age. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Today I talked to Benjamin Breen about his book Tripping on Utopia: Margaret Mead, the Cold War, and the Troubled Birth of Psychedelic Science (Grand Central, 2024). The generation that survived the second World War emerged with a profoundly ambitious sense of social experimentation. In the '40s and '50s, transformative drugs rapidly entered mainstream culture, where they were not only legal, but openly celebrated. American physician John C. Lilly infamously dosed dolphins (and himself) with LSD in a NASA-funded effort to teach dolphins to talk. A tripping Cary Grant mumbled into a Dictaphone about Hegel as astronaut John Glenn returned to Earth. At the centre of this revolution were the pioneering anthropologists - and star-crossed lovers - Margaret Mead and Gregory Bateson. Convinced the world was headed toward certain disaster, Mead and Bateson made it their life's mission to reshape humanity through a new science of consciousness expansion, but soon found themselves at odds with the government bodies who funded their work, whose intentions were less than pure. Mead and Bateson's partnership unlocks an untold chapter in the history of the twentieth century, linking drug researchers with CIA agents, outsider sexologists and the founders of the Information Age. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/history

Today I talked to Benjamin Breen about his book Tripping on Utopia: Margaret Mead, the Cold War, and the Troubled Birth of Psychedelic Science (Grand Central, 2024). The generation that survived the second World War emerged with a profoundly ambitious sense of social experimentation. In the '40s and '50s, transformative drugs rapidly entered mainstream culture, where they were not only legal, but openly celebrated. American physician John C. Lilly infamously dosed dolphins (and himself) with LSD in a NASA-funded effort to teach dolphins to talk. A tripping Cary Grant mumbled into a Dictaphone about Hegel as astronaut John Glenn returned to Earth. At the centre of this revolution were the pioneering anthropologists - and star-crossed lovers - Margaret Mead and Gregory Bateson. Convinced the world was headed toward certain disaster, Mead and Bateson made it their life's mission to reshape humanity through a new science of consciousness expansion, but soon found themselves at odds with the government bodies who funded their work, whose intentions were less than pure. Mead and Bateson's partnership unlocks an untold chapter in the history of the twentieth century, linking drug researchers with CIA agents, outsider sexologists and the founders of the Information Age. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/anthropology

Today I talked to Benjamin Breen about his book Tripping on Utopia: Margaret Mead, the Cold War, and the Troubled Birth of Psychedelic Science (Grand Central, 2024). The generation that survived the second World War emerged with a profoundly ambitious sense of social experimentation. In the '40s and '50s, transformative drugs rapidly entered mainstream culture, where they were not only legal, but openly celebrated. American physician John C. Lilly infamously dosed dolphins (and himself) with LSD in a NASA-funded effort to teach dolphins to talk. A tripping Cary Grant mumbled into a Dictaphone about Hegel as astronaut John Glenn returned to Earth. At the centre of this revolution were the pioneering anthropologists - and star-crossed lovers - Margaret Mead and Gregory Bateson. Convinced the world was headed toward certain disaster, Mead and Bateson made it their life's mission to reshape humanity through a new science of consciousness expansion, but soon found themselves at odds with the government bodies who funded their work, whose intentions were less than pure. Mead and Bateson's partnership unlocks an untold chapter in the history of the twentieth century, linking drug researchers with CIA agents, outsider sexologists and the founders of the Information Age. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/intellectual-history

In Berkeley Talks episode 195, UC Berkeley professors discuss how and why psychedelic substances first evolved, the effects they have in the human brain and mind, and the mechanism behind their potential therapeutic role."If it's true that the therapeutic effects are in part because we're returning to this state of susceptibility, and vulnerability, and ability to learn from our environment similar to childhood," says psychology Professor Gül Dölen, "then if we just focus on the day of the trip and don't instead also focus our therapeutic efforts on those weeks after, where the critical period is presumably still open, then we're missing the opportunity to really integrate those insights that happen during the trip into the rest of the network of memories that are supporting those learned behaviors."And then the caution is that we don't want to be opening up these critical periods and then, for example, returning people to a traumatic environment or exposing them to potentially bad actors … So we want to be very careful about the way that we take care of patients after they've been in this open state of the critical period."Panelists of this March 27, 2024 event included: Imran Khan (moderator): Executive director of the Berkeley Center for the Science of Psychedelics (BCSP).Gül Dölen: Renee & U.S. Marine Lance Cpl. Bob Parsons Endowed Chair in psychology, psychedelics, and neuroscience; professor in the Department of Psychology.Daniela Kaufer: Professor in the Department of Integrative Biology and in the Helen Wills Neuroscience Institute; associate dean of biological sciences.Noah Whiteman: Professor of integrative biology and of molecular and cell biology; faculty director of the Essig Museum of Entomology.Michael Silver: Professor in the Herbert Wertheim School of Optometry and Vision Science and in the Helen Wills Neuroscience Institute; faculty director of BCSP.Listen to the episode and read the transcript on Berkeley News (news.berkeley.edu/podcasts).Music by Blue Dot Sessions.UC Berkeley photo of Daniela Kaufer. Hosted on Acast. See acast.com/privacy for more information.

In this episode, Joe interviews Devon Phillips: community & partnerships officer for the Multidisciplinary Association for Psychedelic Studies (MAPS). Phillips works on strategies to tackle the questions: How do we responsibly mainstream psychedelics? And how do we get culture engaged? He's focusing on being the bridge to psychedelics outside of research, facilitating workshops and psychedelic coming-out stories at music festivals and conferences. He talks about harm reduction and drug checking at festivals, the concept of training big names to become trustworthy resources, the differences found in a hop hop crowd compared to EDM, and the power in using psychedelics for pleasure and celebration – not just healing and growth.  He also discusses:  MAPS' involvement with the NFL for their 'My Cause, My Cleats' campaign, and how the San Francisco 49ers' Jon Feliciano is bringing awareness to psychedelic healing Details about MAPS' first responders training, fiscal sponsorship program, international therapist education program, and upcoming membership program (launching in June) The success of MAPS' Psychedelic Science and his hopes for the 2024 edition, taking place June 16 - 20 at the Denver Convention Center Dr. Carl Hart, drug exceptionalism, and the importance of creating safe containers and inclusive drug policy  and more! For links and more, head to the show notes page.

What if the story of our origins is rooted in lies? What if our accepted societal understanding of our past is wrong? Is it possible that much of our suffering is the result of living life from an erroneous playbook? No other sees more clearly the trappings of BS Inc. than Dr. Chris Ryan. He shares loads of real-talk about the dire challenges confronting our human family and inspires us with a hopeful vision of a future more aligned with our past.    Chris Ryan PhD #104 Show Notes: We Discuss;   -Imbalanced view of the cost of civilization [6:00] -Dr. Ryan's experiences with psychedelics and how they've informed his path [12:25] -Caution about the intersection of psychedelics and commerce [17:30] -Inspiration for writing “Civilized to Death”. Thomas Hobbes “Human life before the state, was solitary, poor, nasty, brutish and short” Bullshit Inc. Lies. [19:20] -Bonobos & Chimps: Our evolutionary roots [30:00] -VET on Tangentially Speaking in 2017 [37:00] -Oregon's Psilocybin Initiative [40:00] -Industrial Addiction Recovery Complex: Our erroneous viewpoint of addiction [46:20]   Helpful Resources: “The Moral Animal” -Robert Wright “Drug Use For Grown-Ups” Dr. Carl Hart  “Fearvana” - Akshay Nanavati    Matt & Ryan on Tangentially Speaking in 2017: https://chrisryanphd.com/266-ryan-lecompte-matt-simpson-vet/ Connect with Dr. Chris Ryan and check out his pioneering work HERE   https://chrisryanphd.com Tangentially Speaking  “Sex at Dawn: The Prehistoric Origins of Modern Sexuality” “Civilized to Death: The Price of Progress”    Worth The Fight Links: IG: @worththefightbook Worth The Fight book: Purchase your copy on Amazon, Kindle, or Audible    Worth The Fight podcast iTunes easy review link   Matt's 1-on-1 Worthy Fight Empowerment Coaching  

Psychedelic drugs have been illegal for 50 years, but they're trickling back into the mainstream because they show promise in helping treat post-traumatic stress disorder and other mental health challenges. We begin the hour with reporter Jonathan A. Davis visiting Psychedelic Science 2023, the largest-ever conference on psychedelic drugs. It's put on by the Multidisciplinary Association for Psychedelic Studies, an organization dedicated to legalizing MDMA (also known as ecstasy or molly) and other psychedelic drugs. Research shows that MDMA-assisted therapy can help treat depression and PTSD, and it's moving toward approval by the U.S. Food and Drug Administration. Psychedelics were studied in the 1950s and '60s as mental health treatments, but the war on drugs put a stop to research. Now, these drugs are gaining bipartisan support from politicians looking for solutions to the mental health crisis among veterans.  Then Reveal's Michael I Schiller visits a group of veterans who are not waiting for psychedelic-assisted therapy to be approved by the federal government. They've joined a church founded by an Iraq War veteran who uses psychedelics as religious sacraments. Schiller accompanies them on a retreat in rural Texas, where they share the depths of their post-traumatic stress and the relief they've felt after psychedelic treatments. He also explores the risks involved in taking these drugs.  We close with an intimate audio diary from a woman in Oakland, California, who's going through therapy with the one psychedelic drug that can be legally prescribed currently in the U.S.: ketamine. Ketamine started out as an anesthetic, but researchers found it can help with treatment-resistant depression when used in tandem with talk therapy. Ketamine can be dangerous if abused, but it also has helped people find relief from mental health issues. This story was produced by Davis.  This is an update of an episode that originally aired in October 2023. Support Reveal's journalism at Revealnews.org/donatenow Subscribe to our weekly newsletter to get the scoop on new episodes at Revealnews.org/newsletter Connect with us on Twitter, Facebook and Instagram Check out independent producer Jonathan A. Davis's work here

If you're listening to this podcast, chances are you've heard stories about the CIA's experiments with drugs, particularly LSD, during the infamous MKUltra program. But you may not know that the characters involved in that dubious effort connect to one of the 20th Century's most famous and revered scientists, the anthropologist Margaret Mead. Shane Harris talked with historian Benjamin Breen about this new book, Tripping on Utopia, which tells the story of how Mead and her close circle launched a movement to expand human consciousness, decades before the counterculture of the 1960s popularized, and ultimately stigmatized, psychedelic drugs. Mead and Gregory Bateson--her collaborator and one-time husband--are at the center of a story that includes the WWII-era Office of Strategic Services, a shady cast of CIA agents and operatives, Beat poets, and the pioneers of the Information Age. Psychedelics are having a renaissance, with federal regulators poised to legalize their use - Breen's book is an engrossing history that explores the roots of that movement and how it influenced and collided with the U.S. national security establishment. Books, movies, and other points of interest discussed in this conversation include: Tripping on Utopia: Margaret Mead, the Cold War, and the Troubled Birth of Psychedelic Science by Benjamin Breen Tripped: Nazi Germany, the CIA, and the Dawn of the Psychedelic Age by Norman Ohler MKUltra The intelligence community's research on “truth drugs” The Manchurian Candidate The Good Shepherd Poisoner in Chief: Sidney Gottlieb and the CIA Search for Mind Control by Stephen Kinzer The Men Who Stare at Goats by Jon Ronson Ghost Hunters: William James and the Search for Scientific Proof of Life After Death by Deborah Blum “Operation Delirium” by Raffi Khatchadourian in The New Yorker Also check out: Ben's website Ben's Substack Ben on Twitter Support this show http://supporter.acast.com/lawfare. Hosted on Acast. See acast.com/privacy for more information.

If you're listening to this podcast, chances are you've heard stories about the CIA's experiments with drugs, particularly LSD, during the infamous MKUltra program. But you may not know that the characters involved in that dubious effort connect to one of the 20th Century's most famous and revered scientists, the anthropologist Margaret Mead. Shane Harris talked with historian Benjamin Breen about this new book, Tripping on Utopia, which tells the story of how Mead and her close circle launched a movement to expand human consciousness, decades before the counterculture of the 1960s popularized, and ultimately stigmatized, psychedelic drugs. Mead and Gregory Bateson--her collaborator and one-time husband--are at the center of a story that includes the WWII-era Office of Strategic Services, a shady cast of CIA agents and operatives, Beat poets, and the pioneers of the Information Age. Psychedelics are having a renaissance, with federal regulators poised to legalize their use - Breen's book is an engrossing history that explores the roots of that movement and how it influenced and collided with the U.S. national security establishment. Books, movies, and other points of interest discussed in this conversation include: Tripping on Utopia: Margaret Mead, the Cold War, and the Troubled Birth of Psychedelic Science by Benjamin Breen Tripped: Nazi Germany, the CIA, and the Dawn of the Psychedelic Age by Norman Ohler MKUltra The intelligence community's research on “truth drugs” The Manchurian Candidate The Good Shepherd Poisoner in Chief: Sidney Gottlieb and the CIA Search for Mind Control by Stephen Kinzer The Men Who Stare at Goats by Jon Ronson Ghost Hunters: William James and the Search for Scientific Proof of Life After Death by Deborah Blum “Operation Delirium” by Raffi Khatchadourian in The New Yorker Also check out: Ben's website Ben's Substack Ben on Twitter Hosted on Acast. See acast.com/privacy for more information.

The twentieth century was something, wasn't it? Margaret Mead, as well as her onetime-husband Gregory Bateson, managed to play roles in several of its key developments: social anthropology and its impact on sex & gender mores, psychedelic drugs and their potential use for therapeutic purposes, and the origin of cybernetics, to name a few. Benjamin Breen discusses this impactful trajectory in his new book, Tripping on Utopia: Margaret Mead, the Cold War, and the Troubled Birth of Psychedelic Science. We talk about Mead and Bateson, the early development of psychedelic drugs, and how the possibility of a realistic utopia didn't always seem so far away.Blog post with transcript: https://www.preposterousuniverse.com/podcast/2024/02/26/267-benjamin-breen-on-margaret-mead-psychedelics-and-utopia/Support Mindscape on Patreon.Benjamin Breen received his Ph.D. in history from the University of Texas at Austin. He is currently an associate professor of history at the University of California, Santa Cruz. Among his awards are the National Endowment for the Humanities Award for Faculty and the William H. Welch Medal of the American Association for the History of Medicine. He writes on Substack at Res Obscura.Web siteUCSC web pageWikipediaAmazon author pageSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Emma Stone is nominated for an Oscar for her starring role in Poor Things. She spoke with Terry Gross about the film and her relationship to her anxiety. David Bianculli reviews Ryan Murphy's FX anthology series Feud: Capote vs. The Swans. Also, Benjamin Breen talks about his book, Tripping on Utopia: Margaret Mead, the Cold War, and the Troubled Birth of Psychedelic Science. It's about the pioneering work anthropologists Margaret Mead and Gregory Bateson did on the use of psychedelics as a way to expand consciousness, and how that later connected to government research on the use of psychedelics as a weapon.

Paul F. Austin welcomes Sunny Strasburg, LMFT, to discuss utilizing IFS & psychedelic-assisted psychotherapy through the Theradelic Approach. Find episode links, summary, and transcript here: https://thethirdwave.co/podcast/episode-232-sunny-strasburg-lmft/ Sunny discusses her multidisciplinary background and how she came to develop her unique therapeutic approach. She incorporates various modalities such as Internal Family Systems (IFS), Eye Movement Desensitization and Reprocessing (EMDR), and the Gottman Method in her work. Sunny emphasizes the importance of personal psychedelic experience for therapists and the need for ethical and well-trained practitioners in the field. She also shares her vision for the future and the challenges of scaling psychedelic therapy while maintaining integrity and respect for the mystery of the psychedelic experience. Sunny Strasburg discusses the Theradelic Approach, which combines Internal Family Systems therapy and psychedelic-assisted therapy. She explains how working with internal parts can lead to self-compassion and coherence. Sunny also shares her experience facilitating Ketamine Assisted Psychotherapy retreats with IFS founder Dick Schwartz, and how they help leaders in various industries lead with self-energy. The conversation then delves into the importance of ethics in artificial intelligence and the potential impact of psychedelics on the AI space. Sunny reflects on the lessons she has learned from plant medicine and emphasizes the importance of being in service and awe.   Sunny Strasburg, LMFT: Sunny Strasburg, LMFT plays a multifaceted role in the fields of psychology and psychedelic therapy, encompassing education, consultation, authorship, and licensed psychotherapy. Her notable literary achievement, "The Theradelic Approach: Psychedelic Therapy: Perspective, Preparation, and Practice," features a foreword by Dr. Richard Schwartz, the creator of the Internal Family Systems model. Through this work, Mrs. Strasburg distills insights drawn from her experiences as an educator, entrepreneur, and psychotherapist. Sunny's professional journey encompasses proficiency in Internal Family Systems and archetypal psychology, alongside certification in Eye Movement Desensitization and Reprocessing (EMDR). As a graduate of Pacifica Graduate Institute and the California Institute of Integral Studies, Mrs. Strasburg holds additional certifications in Psychedelic Assisted Therapy and Research, with specialized knowledge and training in Ketamine, MDMA, and Psilocybin Assisted Psychotherapies. Sunny is the originator and lead educator of The Theradelic Approach, a model of psychedelic-assisted psychotherapy. Her collaboration with Dr. Richard Schwartz and other prominent figures has led to impactful trainings and immersive retreats. Converging the domains of Ketamine Assisted Psychotherapy (KAP), Internal Family Systems (IFS), and Jungian psychology, Mrs. Strasburg has formulated innovative principles and methodologies that elevate therapeutic practices and the conscientious use of psychedelics within clinical frameworks. Sunny's expertise finds expression in prominent conferences like The Psychedelic Summit 2023, Psychedelic Science 2023, SXSW 2023, and the 2023 Expanded States of Consciousness Worldwide Summit. Moreover, her contributions extend to engagements with the 2021 EMDRIA Worldwide Virtual Conference, and her involvement spans diverse platforms, including The Theradelic Approach training, Three Cups Psychedelics, Journey Clinical, Inbodied Training, EMDRIA UK, and the Boston Trauma Conference.   Highlights: Introduction and background Exploring IFS, EMDR, the Gottman Method, & the Theradelic Approach Addressing gaps in psychedelic therapy training The importance of personal psychedelic experience for therapists Understanding trauma mapping Dosage and frequency in ketamine-assisted therapy Working with internal parts using IFS ketamine-assisted psychotherapy retreats for leaders Psychedelics, AI, and ethics Lessons from plant medicine Being in service and awe Resources and trainings   Links: Sunny's website: https://sunnystrasburgtherapy.com/    Sunny's book, “The Theradelic Approach”: https://thetheradelicapproach.com/ Sunny's retreats: https://www.sunnystrasburgretreats.com/   Episode Sponsors: Joyous microdose ketamine. Book your free consultation today! The Coaching Certification Program by Third Wave's Psychedelic Coaching Institute.

GUEST:Critical Consulting: https://www.critical.consulting/blog   Entheome: https://www.entheome.org/team-members/ian-bollinger   Hyphae Labs: https://www.patreon.com/hyphaelabsOakland Hyphae: https://www.oaklandhyphae510.com/   MENTIONS:    https://en.wikipedia.org/wiki/Psilocybe_zapotecorum   https://en.wikipedia.org/wiki/Panaeolus_cyanescens   FunDiS: https://fundis.org/   Mycelial Mass: https://www.facebook.com/groups/mycelialmass/   MUSHROOM HOUR:   https://welcometomushroomhour.com   https://instagram.com/welcome_to_mushroom_hour   https://tiktok.com/@welcome_to_mushroom_hour   Show Music courtesy of the one and only Chris Peck: https://peckthetowncrier.bandcamp.com/   TOPICS COVERED:    Chemical Analysis & Community Science   Human Beings as Scientists by Nature   Gatekeeping vs Guardianship   Tryptamines, Nucleocides, Ibotenic acid, Muscimol, Muscarine   Chromatograph Clusters   The Hyphae Spectrum    Empowering Producers and Consumers with Analysis   What Compounds are in Fungi?   Hyphae Labs & the Center for Mycological Analytics   Bioinformatics    Field Studies in Mexico   Muscimol-Containing Mushrooms are the Ancestors of Psilocybin-Containing Mushrooms?!   Field Studies and International Research Stations    Ian's Surreal Journey   

In this episode, Joe interviews Erik Vaughan: Co-Founder and Manager of Epiphany mushrooms, a mushroom and mental health company based in Akron, Ohio. Epiphany mushrooms will initially be selling Lion's Mane, Reishi, and Cordyceps, and they plan to expand into more functional mushrooms while also pursuing a license to operate healing centers in Colorado. Vaughan was involved in changing Colorado's psilocybin legislation after lobbying to add a section that allows product testing labs to register and charge for their services – while voluntary and complementary to required testing, it allows growers to have an unlimited amount of product for testing purposes; adds an extra step in keeping the grower and lab in compliance with state law; and, as more states work on their own legislation, highlights the need for potency testing to let customers know exactly what they're ingesting.  He discusses changing attitudes and how Michigan can lead the way for the midwest; why he's excited about Colorado and what they got right; the enthusiasm of the mycology crowd; Rick Perry's speech at Psychedelic Science 2023; the iron law of prohibition and mushroom products sold in Ohio; and the incredible inefficiency of the drug war (when viewed like it was not designed to do exactly what it's doing). Click here to head to the show notes page.

You may have heard about the pioneering research of anthropologist Margaret Mead, but do you know about her work with psychedelics? Mead and her husband, Gregory Bateson, thought psychedelics might reshape humanity by expanding consciousness. We'll speak with author Benjamin Breen about that research and how it led to the CIA's secret experiments in the '50s and '60s, using psychedelics in interrogation. He also shares with us details about a NASA-funded experiment to try to get dolphins to talk by giving them LSD. His book is Tripping on Utopia.Also, John Powers reviews the Apple TV+ series Criminal Record.

Psychedelic drugs have been illegal for 50 years, but they're trickling back into the mainstream because they show promise in helping treat post-traumatic stress disorder and other mental health challenges. We begin the hour with reporter Jonathan A. Davis visiting Psychedelic Science 2023, the largest-ever conference on psychedelic drugs. It's put on by the Multidisciplinary Association for Psychedelic Studies, an organization dedicated to legalizing MDMA (also known as ecstasy or molly) and other psychedelic drugs. Research shows that MDMA-assisted therapy can help treat depression and PTSD, and it's moving toward approval by the U.S. Food and Drug Administration. Psychedelics were studied in the 1950s and '60s as mental health treatments, but the war on drugs put a stop to research. Now, these drugs are gaining bipartisan support from politicians looking for solutions to the mental health crisis among veterans.  Then Reveal's Michael I Schiller visits a group of veterans who are not waiting for psychedelic-assisted therapy to be approved by the federal government. They've joined a church founded by an Iraq War veteran who uses psychedelics as religious sacraments. Schiller accompanies them on a retreat in rural Texas, where they share the depths of their post-traumatic stress and the relief they've felt after psychedelic treatments. He also explores the risks involved in taking these drugs.  We close with an intimate audio diary from a woman in Oakland, California, who's going through therapy with the one psychedelic drug that can be legally prescribed currently in the U.S.: ketamine. Ketamine started out as an anesthetic, but researchers found it can help with treatment-resistant depression when used in tandem with talk therapy. Ketamine can be dangerous if abused, but it also has helped people find relief from mental health issues. This story was produced by Davis. Support Reveal's journalism at Revealnews.org/donatenow Subscribe to our weekly newsletter to get the scoop on new episodes at Revealnews.org/newsletter Connect with us on Twitter, Facebook and Instagram Check out independent producer Jonathan A. Davis's work here